BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) continued to receive encouraging news on its enzyme replacement therapy Vimizim (elosulfase alfa), when the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the drug’s approval in the EU for treating patients suffering from mucopolysaccharidosis type IVA (MPS IVA). BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stock opened at $80.16 in last session, and closed at $81.52, while the day range of stock is $79.75 – $82.09. The stock showed a positive weekly performance of 7.36%.
Oppenheimer downgraded shares of magicJack VocalTec (NASDAQ:CALL) from an outperform rating to a market perform rating in a research note released on Thursday morning, TheFlyOnTheWall.com reports. The analysts noted that the move was a valuation call. magicJack VocalTec Ltd (NASDAQ:CALL) stock opened at $19.88, in last session and closed at $19.65, by losing -1.16%. The 52 week range of the stock is $10.67 – $20.38. Company’s market capitalization is $364.56 million.
Investment analysts at Barclays lifted their target price on shares of Jack in the Box (NASDAQ:JACK) from $49.00 to $54.00 in a note issued to investors on Thursday, StockRatingsNetwork.com reports. The firm currently has an “equal weight” rating on the stock. Barclays’ price target suggests a potential downside of 6.46% from the company’s current price. Jack in the Box Inc. (NASDAQ:JACK) stock advanced 0.29% and finished the last session at $57.90. The EPS of the stock remained 1.84. Company’s market capitalization is $2.49 billion.
Eli Lilly & Co. (NYSE:LLY) stock had its “positive” rating reaffirmed by equities research analysts at Needham & Company in a research note issued to investors on Wednesday, AnalystRatings.Net reports. Eli Lilly & Co. (NYSE:LLY) stock opened the session at $58.10, and closed the session at $57.96. The 52 week range of the stock remained $47.53 – $58.76 and the day range was $57.77 – $58.76.